Professor Hari Jayaram

Age ranges treated

• Adults (age 16 and above)

Qualifications / Professional memberships

• MA (Hons) University of Cambridge
• BMBCh University of Oxford
• Postgraduate Diploma (Research Ethics) University of Keele
• PhD (Retinal Stem Cell Biology) University College London
• MSc (Distinction) (Clinical Trials), University of London
• Fellow, Royal College of Surgeons, Edinburgh
• Fellow, Royal College of Ophthalmologists, London
• Fellow, Association for Research & Vision in Ophthalmology
• Member, European Society of Cataract and Refractive Surgeons
• Member, European Glaucoma Society

Current NHS / University Post

• Consultant Ophthalmic Surgeon, Moorfields Eye Hospital NHS Foundation Trust, London

• Director, Glaucoma Service, Moorfields Eye Hospital NHS Foundation Trust

• Co-Chair, Research Management Committee, Moorfields Eye Hospital NHS Foundation Trust

• Co-Theme Lead, Regenerative Therapies, Lasers & Medical Devices, NIHR Moorfields Biomedical Research Centre 

• Professor of Ophthalmology, University College London

Medical training

• Christ’s College, University of Cambridge
• Oriel College, University of Oxford
• Basic Ophthalmology Specialist Training, St Thomas’ Hospital, London
• Higher Ophthalmology Specialist Training, Moorfields Eye Hospital NHS Foundation Trust, London
• Clinical Glaucoma Fellowship, Moorfields Eye Hospital NHS Foundation Trust, London

Research interest / experience

• Vice-Chair, City Road & Hampstead NHS Research Ethics Committee (2008-2014)

• Medical Research Council (UK) / RCSEd Clinical Research Training Fellowship (2008-2011)

• National Institute for Health Research (NIHR) Academic Clinical Lecturership (2011-14)

• Fulbright Scholarship, Casey Eye Institute, Portland, Oregon, USA (2014-16)

Current Areas of Research:

• Translational laboratory research towards novel treatments for glaucoma, Laboratory Models of Glaucomatous Optic Nerve Damage, Development of Stem Cell Therapies for Glaucoma.

• Glaucoma Surgical Outcomes, Patient Involvement in Translational Eye Research, Clinical Trials, Minimally Invasive Glaucoma Surgeries.

Languages spoken

• English